BALYASNY ASSET MANAGEMENT L.P. - KARUNA THERAPEUTICS INC ownership

KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 295 filers reported holding KARUNA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.6%.

Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of KARUNA THERAPEUTICS INC
ValueSharesWeighting
Q4 2023$99,982,977
+448.5%
315,892
+193.0%
0.19%
+408.1%
Q3 2023$18,227,733
+1265.3%
107,799
+1366.7%
0.04%
+1133.3%
Q1 2023$1,335,054
-78.6%
7,350
-76.8%
0.00%
-82.4%
Q4 2022$6,235,731
-32.3%
31,734
-56.4%
0.02%
-43.3%
Q2 2022$9,210,00072,8020.03%
Other shareholders
KARUNA THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Sofinnova Investments, Inc. 1,885,602$135,763,00012.56%
PFM Health Sciences, LP 499,510$35,965,0002.95%
Eventide Asset Management 901,077$64,878,0002.10%
ACUTA CAPITAL PARTNERS, LLC 56,000$4,032,0001.95%
Logos Global Management LP 69,658$5,015,0001.91%
Vivo Capital, LLC 223,692$16,106,0001.46%
Atika Capital Management LLC 90,000$6,480,0001.24%
EAM Global Investors LLC 27,126$1,953,0001.14%
EAM Investors, LLC 40,516$2,917,0000.91%
MOODY ALDRICH PARTNERS LLC 25,844$1,861,0000.56%
View complete list of KARUNA THERAPEUTICS INC shareholders